3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and quetiapine fumarate

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with quetiapine fumarate in 4 studies

Compound Research Comparison

Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)	Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)	Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)	Studies (quetiapine fumarate)	Trials (quetiapine fumarate)	Recent Studies (post-2010) (quetiapine fumarate)
330	40	33	3,162	619	1,456

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asenbaum, S; Brücke, T; Kasper, S; Küfferle, B; Tauscher, J	1
Asenbaum, S; Brücke, T; Kasper, S; Küfferle, B; Podreka, I; Tauscher, J; Vesely, C	1
Seeman, P; Tallerico, T	1
Ambrus, E; Argyelán, M; Csernay, L; Janka, Z; Kanyó, B; Kéri, S; Kovács, Z; Pávics, L; Szekeres, G	1

Trials

2 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and quetiapine fumarate

Article	Year
IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol. Psychopharmacology, 1997, Volume: 133, Issue:4 Topics: Adult; Antipsychotic Agents; Benzamides; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Neostriatum; Psychotic Disorders; Pyrrolidines; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon	1997
The prognostic value of dopamine receptor occupancy by [123I]IBZM-SPECT in schizophrenic patients treated with quetiapine. Nuclear medicine review. Central & Eastern Europe, 2004, Volume: 7, Issue:2 Topics: Adult; Antipsychotic Agents; Benzamides; Corpus Striatum; Dibenzothiazepines; Female; Humans; Male; Prognosis; Pyrrolidines; Quetiapine Fumarate; Radiopharmaceuticals; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2004

Article

Year

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.

Psychopharmacology, 1997, Volume: 133, Issue:4

Topics: Adult; Antipsychotic Agents; Benzamides; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Neostriatum; Psychotic Disorders; Pyrrolidines; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon

1997

The prognostic value of dopamine receptor occupancy by [123I]IBZM-SPECT in schizophrenic patients treated with quetiapine.

Nuclear medicine review. Central & Eastern Europe, 2004, Volume: 7, Issue:2

Topics: Adult; Antipsychotic Agents; Benzamides; Corpus Striatum; Dibenzothiazepines; Female; Humans; Male; Prognosis; Pyrrolidines; Quetiapine Fumarate; Radiopharmaceuticals; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2004

Other Studies

2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and quetiapine fumarate

Article	Year
Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine. Psychopharmacology, 1997, Volume: 133, Issue:1 Topics: Adult; Antipsychotic Agents; Benzamides; Confounding Factors, Epidemiologic; Corpus Striatum; Dibenzothiazepines; Humans; Iodine Radioisotopes; Male; Pyrrolidines; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon	1997
Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. The American journal of psychiatry, 1999, Volume: 156, Issue:6 Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Carbon Radioisotopes; Cloning, Molecular; Clozapine; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Mice; Pyrrolidines; Quetiapine Fumarate; Raclopride; Radionuclide Imaging; Receptors, Dopamine D2; Salicylamides; Spodoptera; Substance Withdrawal Syndrome; Tritium	1999

Article

Year

Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine.

Psychopharmacology, 1997, Volume: 133, Issue:1

Topics: Adult; Antipsychotic Agents; Benzamides; Confounding Factors, Epidemiologic; Corpus Striatum; Dibenzothiazepines; Humans; Iodine Radioisotopes; Male; Pyrrolidines; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon

1997

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.

The American journal of psychiatry, 1999, Volume: 156, Issue:6

Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Carbon Radioisotopes; Cloning, Molecular; Clozapine; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Mice; Pyrrolidines; Quetiapine Fumarate; Raclopride; Radionuclide Imaging; Receptors, Dopamine D2; Salicylamides; Spodoptera; Substance Withdrawal Syndrome; Tritium

1999